Analysts Set Hyperfine, Inc. (NASDAQ:HYPR) Price Target at $1.45

Hyperfine, Inc. (NASDAQ:HYPR) has earned a consensus rating of “Hold” from the five brokerages that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $1.45.

HYPR has been the topic of several research reports. Zacks Research upgraded Hyperfine to a “hold” rating in a research note on Thursday, March 19th. Lake Street Capital increased their price objective on shares of Hyperfine from $2.00 to $2.50 and gave the stock a “buy” rating in a research note on Thursday, March 19th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperfine in a report on Thursday, January 22nd.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. EP Wealth Advisors LLC bought a new stake in Hyperfine during the fourth quarter valued at about $34,000. XTX Topco Ltd lifted its holdings in Hyperfine by 47.9% in the 4th quarter. XTX Topco Ltd now owns 80,735 shares of the company’s stock worth $79,000 after purchasing an additional 26,165 shares in the last quarter. Millennium Management LLC purchased a new position in Hyperfine in the 4th quarter worth approximately $55,000. Catalio Capital Management LP boosted its stake in Hyperfine by 92.8% in the 4th quarter. Catalio Capital Management LP now owns 1,320,041 shares of the company’s stock worth $1,293,000 after purchasing an additional 635,500 shares during the period. Finally, Bridgeway Capital Management LLC boosted its stake in Hyperfine by 50.2% in the 4th quarter. Bridgeway Capital Management LLC now owns 119,700 shares of the company’s stock worth $117,000 after purchasing an additional 40,000 shares during the period. Hedge funds and other institutional investors own 15.03% of the company’s stock.

Hyperfine Price Performance

NASDAQ HYPR opened at $1.22 on Friday. The stock has a market capitalization of $118.06 million, a price-to-earnings ratio of -2.76 and a beta of 1.09. Hyperfine has a 1-year low of $0.53 and a 1-year high of $2.22. The business’s fifty day moving average price is $1.16 and its 200-day moving average price is $1.20.

Hyperfine (NASDAQ:HYPR) last issued its quarterly earnings data on Wednesday, March 18th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.02. The company had revenue of $5.29 million during the quarter, compared to analyst estimates of $5.30 million. Hyperfine had a negative return on equity of 95.09% and a negative net margin of 262.29%. Equities research analysts anticipate that Hyperfine will post -0.57 EPS for the current year.

About Hyperfine

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.